The recent surge in capital into niche pharmaceutical companies, particularly those focusing on groundbreaking therapies and complex drug development programs, has fueled what some are calling "High Roller Pharma." https://diegokqrx635118.diowebhost.com/95260101/premium-roller-pharma-the-hazardous-bet